KYMR Kymera Therapeutics, Inc.
Nasdaq · SEC CIK 1815442 · EDGAR
- Bought, last 12 months
- $172.50M 1 purchases by 1 insiders
- Sold, last 12 months
- $475.84M 50 sales by 11 insiders
- Filings on record
- 212 since 2021-07-06, latest 2026-09-04 18:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Booth Bruce | Dir | — | $226.03M |
| BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| BAKER FELIX | Dir, 10% | $172.50M | — |
| Mainolfi Nello | CEO, Dir | — | $33.41M |
| Chadwick Jeremy G | COO | — | $15.60M |
| Jacobs Bruce N. | CFO | — | $9.96M |
| Gollob Jared | Chief Medical Off | — | $9.13M |
| Esposito Pamela | Dir | — | $3.05M |
| Goodman Noah | Chief Business Off | — | $2.22M |
| Ridloff Elena | Dir | — | $1.29M |
Transactions 233
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-04 18:00 | 2026-09-04 | KYMR | Adams Brian | CLO | S - Sale | $116.83 | -6,371 | 50.3K | -11% | -$744.3K |
| D | 2026-07-27 18:34 | 2026-07-27 | KYMR | Rooney Terence | Chief Medical Off | A - Grant | $0.00 | +38.0K | 38.0K | New | $0 |
| DT | 2026-07-07 20:00 | 2026-07-07 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +50.0K | 716.6K | +8% | +$104.0K |
| DT | 2026-07-07 20:00 | 2026-07-07 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $119.00 | -50.0K | 666.6K | -7% | -$5.95M |
| DT | 2026-07-02 18:30 | 2026-06-30 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $5.33 | +61.4K | 322.0K | +24% | +$327.1K |
| DMT | 2026-07-02 18:30 | 2026-06-30 | KYMR | Jacobs Bruce N. | CFO | S - Sale+OE | $114.96 | -77.1K | 244.9K | -24% | -$8.86M |
| T | 2026-07-02 18:30 | 2026-07-01 | KYMR | Goodman Noah | Chief Business Off | S - Sale | $114.29 | -3,389 | 47.2K | -7% | -$387.3K |
| DT | 2026-07-02 18:30 | 2026-07-01 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +80.0K | 746.6K | +12% | +$166.4K |
| DMT | 2026-07-02 18:30 | 2026-07-01 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $115.29 | -80.0K | 666.6K | -11% | -$9.22M |
| MATI | 2026-07-02 17:39 | 2026-06-29 | KYMR | Booth Bruce | Dir | S - Sale | $108.05 | -76.7K | 462.9K | -14% | -$8.28M |
| MTI | 2026-06-30 17:32 | 2026-06-29 | KYMR | Booth Bruce | Dir | S - Sale | $109.48 | -31.3K | 461.8K | -6% | -$3.42M |
| MTI | 2026-06-30 17:30 | 2026-06-26+ | KYMR | Booth Bruce | Dir | S - Sale | $110.01 | -513.2K | 466.1K | -52% | -$56.46M |
| M | 2026-06-26 18:48 | 2026-06-26 | KYMR | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | S - Sale | $106.50 | -1.58M | 240.1K | -87% | -$168.14M |
| I | 2026-06-26 18:48 | 2026-06-26 | KYMR | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | S - Sale | $106.50 | -51.9K | 78.8K | -40% | -$5.52M |
| MTI | 2026-06-25 21:56 | 2026-06-25 | KYMR | Booth Bruce | Dir | S - Sale | $121.86 | -285.7K | 529.7K | -35% | -$34.81M |
| MTI | 2026-06-25 21:55 | 2026-06-23+ | KYMR | Booth Bruce | Dir | S - Sale | $110.31 | -398.8K | 564.7K | -41% | -$43.99M |
| DT | 2026-06-25 18:00 | 2026-06-25 | KYMR | Goodman Noah | Chief Business Off | M - OptEx | $21.05 | +5,000 | 55.2K | +10% | +$105.2K |
| DMT | 2026-06-25 18:00 | 2026-06-25 | KYMR | Goodman Noah | Chief Business Off | S - Sale+OE | $114.00 | -5,000 | 50.2K | -9% | -$570.0K |
| MTI | 2026-06-22 21:02 | 2026-06-22 | KYMR | Booth Bruce | Dir | S - Sale | $103.75 | -31.8K | 613.8K | -5% | -$3.30M |
| DT | 2026-06-22 21:01 | 2026-06-17 | KYMR | Booth Bruce | Dir | M - OptEx | $20.00 | +11.7K | 11.7K | New | +$234.8K |
| DT | 2026-06-22 21:01 | 2026-06-17 | KYMR | Booth Bruce | Dir | S - Sale+OE | $89.98 | -11.7K | 0 | -100% | -$1.06M |
| DMTI | 2026-06-22 21:01 | 2026-06-17+ | KYMR | Booth Bruce | Dir | S - Sale+OE | $94.84 | -466.5K | 617.7K | -43% | -$44.24M |
| DT | 2026-06-22 17:47 | 2026-06-22 | KYMR | Goodman Noah | Chief Business Off | M - OptEx | $21.05 | +2,500 | 52.7K | +5% | +$52.6K |
| DT | 2026-06-22 17:47 | 2026-06-22 | KYMR | Goodman Noah | Chief Business Off | S - Sale+OE | $99.00 | -2,500 | 50.2K | -5% | -$247.5K |
| D | 2026-06-03 07:30 | 2026-06-02 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $2.08 | +12.7K | 260.2K | +5% | +$26.3K |
| MT | 2026-05-27 17:50 | 2026-05-26+ | KYMR | Chadwick Jeremy G | COO | S - Sale | $79.92 | -17.2K | 44.0K | -28% | -$1.37M |
| D | 2026-05-19 16:05 | 2026-05-19 | KYMR | Esposito Pamela | Dir | M - OptEx | $31.20 | +1,000 | 1,000 | New | +$31.2K |
| D | 2026-05-19 07:30 | 2026-05-18 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $2.08 | +15.0K | 247.6K | +6% | +$31.2K |
| DT | 2026-05-11 16:58 | 2026-05-11 | KYMR | Ridloff Elena | Dir | M - OptEx | $31.20 | +3,000 | 3,000 | New | +$93.6K |
| DT | 2026-05-11 16:58 | 2026-05-11 | KYMR | Ridloff Elena | Dir | S - Sale+OE | $87.00 | -3,000 | 0 | -100% | -$261.0K |
| DT | 2026-04-29 17:00 | 2026-04-29 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 696.2K | +5% | +$62.4K |
| DMT | 2026-04-29 17:00 | 2026-04-29 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $81.18 | -30.0K | 666.2K | -4% | -$2.44M |
| DMT | 2026-04-24 16:33 | 2026-04-22 | KYMR | Booth Bruce | Dir | M - OptEx | $14.44 | +5,900 | 5,900 | New | +$85.2K |
| DT | 2026-04-24 16:33 | 2026-04-22 | KYMR | Booth Bruce | Dir | S - Sale+OE | $89.96 | -5,900 | 0 | -100% | -$530.8K |
| DMTI | 2026-04-24 16:33 | 2026-04-22 | KYMR | Booth Bruce | Dir | S - Sale+OE | $90.08 | -100 | 674.9K | -0.0% | -$9,008 |
| DMT | 2026-04-24 16:30 | 2026-04-22 | KYMR | Chadwick Jeremy G | COO | M - OptEx | $39.06 | +300 | 61.5K | +0.5% | +$11.7K |
| DT | 2026-04-24 16:30 | 2026-04-22 | KYMR | Chadwick Jeremy G | COO | S - Sale+OE | $90.00 | -300 | 61.2K | -0.5% | -$27.0K |
| T | 2026-04-16 18:30 | 2026-04-14 | KYMR | Goodman Noah | Chief Business Off | S - Sale | $90.00 | -1,347 | 50.2K | -3% | -$121.2K |
| DMT | 2026-04-16 18:30 | 2026-04-14+ | KYMR | Chadwick Jeremy G | COO | M - OptEx | $34.41 | +6,551 | 62.5K | +12% | +$225.4K |
| DMT | 2026-04-16 18:30 | 2026-04-14+ | KYMR | Chadwick Jeremy G | COO | S - Sale+OE | $90.00 | -6,551 | 61.2K | -10% | -$589.6K |
| DMT | 2026-04-16 18:16 | 2026-04-14+ | KYMR | Booth Bruce | Dir | M - OptEx | $14.18 | +6,359 | 2,200 | New | +$90.2K |
| DMT | 2026-04-16 18:16 | 2026-04-14+ | KYMR | Booth Bruce | Dir | S - Sale+OE | $89.96 | -6,359 | 0 | -100% | -$572.1K |
| DMTI | 2026-04-16 18:16 | 2026-04-15 | KYMR | Booth Bruce | Dir | S - Sale+OE | $90.10 | -3,135 | 675.0K | -0.5% | -$282.5K |
| DT | 2026-04-10 16:45 | 2026-04-09 | KYMR | Goodman Noah | Chief Business Off | M - OptEx | $21.05 | +2,500 | 61.8K | +4% | +$52.6K |
| DMT | 2026-04-10 16:45 | 2026-04-09+ | KYMR | Goodman Noah | Chief Business Off | S - Sale+OE | $87.47 | -10.3K | 51.5K | -17% | -$897.8K |
| DMT | 2026-04-01 19:00 | 2026-03-31+ | KYMR | Ridloff Elena | Dir | M - OptEx | $14.18 | +12.0K | 4,600 | New | +$170.2K |
| DMT | 2026-04-01 19:00 | 2026-03-31+ | KYMR | Ridloff Elena | Dir | S - Sale+OE | $85.39 | -12.0K | 0 | -100% | -$1.02M |
| DMT | 2026-04-01 19:00 | 2026-03-31+ | KYMR | Chadwick Jeremy G | COO | M - OptEx | $29.64 | +22.2K | 75.8K | +41% | +$659.2K |
| DMT | 2026-04-01 19:00 | 2026-03-31+ | KYMR | Chadwick Jeremy G | COO | S - Sale+OE | $85.43 | -22.2K | 61.2K | -27% | -$1.90M |
| DMT | 2026-03-25 | 2026-03-23+ | KYMR | Chadwick Jeremy G | COO | M - OptEx | $29.64 | +109.1K | 152.5K | +252% | +$3.23M |
| DMT | 2026-03-25 | 2026-03-23+ | KYMR | Chadwick Jeremy G | COO | S - Sale+OE | $78.02 | -116.0K | 61.2K | -65% | -$9.05M |
| DMT | 2026-03-20 | 2026-03-20 | KYMR | Esposito Pamela | Dir | S - Sale+OE | $79.15 | -2,500 | 1,800 | -58% | -$197.9K |
| DT | 2026-03-20 | 2026-03-20 | KYMR | Esposito Pamela | Dir | M - OptEx | $49.10 | +2,500 | 2,500 | New | +$122.8K |
| DT | 2026-03-11 | 2026-03-11 | KYMR | Chadwick Jeremy G | COO | M - OptEx | $43.50 | +20.0K | 93.8K | +27% | +$870.0K |
| DMT | 2026-03-11 | 2026-03-11 | KYMR | Chadwick Jeremy G | COO | S - Sale+OE | $83.30 | -25.8K | 68.1K | -27% | -$2.15M |
| MI | 2026-03-04 | 2026-03-02 | KYMR | Booth Bruce | Dir | S - Sale | $90.13 | -81.9K | 3.90M | -2% | -$7.38M |
| D | 2026-03-04 | 2026-03-02 | KYMR | Goodman Noah | Chief Business Off | A - Grant | $0.00 | +9,225 | 59.3K | +18% | $0 |
| DM | 2026-03-04 | 2026-03-02+ | KYMR | Gollob Jared | Chief Medical Off | S - Sale | $87.24 | -10.5K | 117.1K | -8% | -$916.7K |
| D | 2026-03-04 | 2026-03-02 | KYMR | Gollob Jared | Chief Medical Off | A - Grant | $0.00 | +17.6K | 127.6K | +16% | $0 |
| DM | 2026-03-04 | 2026-03-02+ | KYMR | Chadwick Jeremy G | COO | S - Sale | $86.54 | -5,958 | 79.2K | -7% | -$515.6K |
| D | 2026-03-04 | 2026-03-02 | KYMR | Chadwick Jeremy G | COO | A - Grant | $0.00 | +12.6K | 79.8K | +19% | $0 |
| D | 2026-03-04 | 2026-03-02 | KYMR | Adams Brian | CLO | A - Grant | $0.00 | +4,125 | 56.6K | +8% | $0 |
| DM | 2026-03-04 | 2026-03-02+ | KYMR | Jacobs Bruce N. | CFO | S - Sale | $87.50 | -12.5K | 234.5K | -5% | -$1.09M |
| D | 2026-03-04 | 2026-03-02 | KYMR | Jacobs Bruce N. | CFO | A - Grant | $0.00 | +17.6K | 245.1K | +8% | $0 |
| DMT | 2026-02-25 | 2026-02-25 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $90.26 | -30.0K | 671.0K | -4% | -$2.71M |
| DT | 2026-02-25 | 2026-02-25 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 696.2K | +5% | +$62.4K |
| DT | 2026-02-20 | 2026-02-20 | KYMR | Esposito Pamela | Dir | M - OptEx | $49.10 | +2,500 | 2,500 | New | +$122.8K |
| DMT | 2026-02-20 | 2026-02-20 | KYMR | Esposito Pamela | Dir | S - Sale+OE | $87.31 | -2,500 | 0 | -100% | -$218.3K |
| DMT | 2026-01-20 | 2026-01-20 | KYMR | Esposito Pamela | Dir | S - Sale+OE | $67.91 | -5,500 | 200 | -96% | -$373.5K |
| DMT | 2026-01-20 | 2026-01-20 | KYMR | Esposito Pamela | Dir | M - OptEx | $39.34 | +5,500 | 5,500 | New | +$216.3K |
| D | 2026-01-06 | 2026-01-05 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $32.07 | +3,118 | 666.2K | +0.5% | +$100.0K |
| DT | 2025-12-31 | 2025-12-31 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 693.1K | +5% | +$62.4K |
| DMT | 2025-12-31 | 2025-12-31 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $78.06 | -30.0K | 669.1K | -4% | -$2.34M |
| DMT | 2025-12-17 | 2025-12-17 | KYMR | Esposito Pamela | Dir | M - OptEx | $37.82 | +27.6K | 12.6K | New | +$1.04M |
| DMT | 2025-12-17 | 2025-12-17 | KYMR | Esposito Pamela | Dir | S - Sale+OE | $82.16 | -27.6K | 13.1K | -68% | -$2.26M |
| D | 2025-12-17 | 2025-12-17 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $38.53 | +2,595 | 663.1K | +0.4% | +$100.0K |
| MI | 2025-12-12 | 2025-12-10+ | KYMR | Booth Bruce | Dir | S - Sale | $91.72 | -236.6K | 4.11M | -5% | -$21.70M |
| MI | 2025-12-11 | 2025-12-11 | KYMR | BAKER FELIX | Dir, 10% | P - Purchase | $86.00 | +2.01M | 7.96M | +34% | +$172.50M |
| DMT | 2025-12-08 | 2025-12-08 | KYMR | Albers Jeffrey W. | Dir | S - Sale+OE | $89.76 | -5,000 | 2,252 | -69% | -$448.8K |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Albers Jeffrey W. | Dir | M - OptEx | $14.18 | +5,000 | 5,000 | New | +$70.9K |
| DMT | 2025-12-08 | 2025-12-08 | KYMR | Gollob Jared | Chief Medical Off | S - Sale+OE | $88.66 | -49.3K | 110.0K | -31% | -$4.37M |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $5.33 | +49.3K | 159.3K | +45% | +$262.8K |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +100.0K | 760.5K | +15% | +$208.0K |
| DT | 2025-12-08 | 2025-12-08 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $89.17 | -100.0K | 660.5K | -13% | -$8.92M |
| DT | 2025-10-29 | 2025-10-29 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 690.5K | +5% | +$62.4K |
| DMT | 2025-10-29 | 2025-10-29 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.99 | -30.0K | 664.1K | -4% | -$1.83M |
| DMT | 2025-10-15 | 2025-10-15 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $1.64 | +51.2K | 147.4K | +53% | +$84.2K |
| DMT | 2025-10-15 | 2025-10-15 | KYMR | Gollob Jared | Chief Medical Off | S - Sale+OE | $61.42 | -59.6K | 131.3K | -31% | -$3.66M |
| DT | 2025-10-14 | 2025-10-13 | KYMR | Albers Jeffrey W. | Dir | M - OptEx | $10.34 | +5,000 | 5,000 | New | +$51.7K |
| DT | 2025-10-14 | 2025-10-13 | KYMR | Albers Jeffrey W. | Dir | S - Sale+OE | $59.19 | -5,000 | 0 | -100% | -$295.9K |
| DMT | 2025-10-14 | 2025-10-13 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $1.66 | +1,473 | 120.8K | +1% | +$2,448 |
| DT | 2025-10-14 | 2025-10-13 | KYMR | Gollob Jared | Chief Medical Off | S - Sale+OE | $60.00 | -3,114 | 118.4K | -3% | -$186.8K |
| DT | 2025-09-17 | 2025-09-17 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $2.08 | +79.2K | 306.6K | +35% | +$164.8K |
| DT | 2025-09-17 | 2025-09-17 | KYMR | Jacobs Bruce N. | CFO | S - Sale+OE | $50.00 | -79.2K | 227.4K | -26% | -$3.96M |
| DT | 2025-09-16 | 2025-09-16 | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $49.00 | -30.0K | 660.5K | -4% | -$1.47M |
| DT | 2025-09-16 | 2025-09-16 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +30.0K | 690.5K | +5% | +$62.4K |
| D | 2025-09-03 | 2025-09-03 | KYMR | Adams Brian | CLO | A - Grant | $0.00 | +52.5K | 52.5K | New | $0 |
| DM | 2025-07-01 | 2025-06-30 | KYMR | Biotechnology Value Trading Fund OS LP | Dir, See Remarks, Footnotes | P - Purchase | $44.00 | +317.2K | 2.80M | +13% | +$13.96M |
| DMI | 2025-06-30 | 2025-06-30 | KYMR | Baker Bros. Advisors (GP) LLC | Dir | P - Purchase | $44.00 | +655.5K | 6.12M | +12% | +$28.84M |
| DT | 2025-06-11 | 2025-06-11 | KYMR | Ridloff Elena | Dir | S - Sale+OE | $50.00 | -4,500 | 0 | -100% | -$225.0K |
Purchase Sale Sale after option exercise All abbreviations